Horizon Therapeutics Competitors and Similar CompaniesClear all

Horizon Therapeutics's competitors and similar companies include Roivant Sciences, Amarin, Cartesian Therapeutics, Ultragenyx, Avrobio, Arcturus Therapeutics and Aeglea.
Horizon Therapeutics
Horizon Therapeutics
Horizon Therapeutics (formerly known as Horizon Pharma) is a biopharmaceutical company focused on researching, developing, and commercializing medicines.
Roivant Sciences
Roivant Sciences
Roivant Sciences is a company that develops and commercializes medicines.
Amarin
Amarin
Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.
Cartesian Therapeutics
Cartesian Therapeutics
Cartesian Therapeutics (formerly Selecta Biosciences) is a clinical-stage biopharmaceutical company advancing a differentiated product pipeline to modulate the immune system.
Ultragenyx
Ultragenyx
Ultragenyx Pharmaceutical is a company that develops therapies for rare genetic diseases.
Avrobio
Avrobio
Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Arcturus Therapeutics
Arcturus Therapeutics
Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company.
Aeglea
Aeglea
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics.
Founding Date
Founding Date
2008
Founding Date
2014
Founding Date
1991
Founding Date
2007
Founding Date
2010
Founding Date
N/A
Founding Date
2013
Founding Date
2013
Type
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Dublin, IE HQ
Locations
London, GB HQ
Basel, CH
Boston, US
New York, US
Locations
Dublin, IE HQ
Zug, CH
Bridgewater Township, US
Locations
Watertown, US HQ
Locations
Novato, US HQ
Buenos Aires, AR
São Paulo, BR
Bogotá, CO
Paris, FR
Berlin, DE
Tokyo, JP
see more
Locations
Cambridge, US HQ
Locations
San Diego, US HQ
Locations
Austin, US HQ
Employees
Employees
2,6691% increase
Employees
908
Employees
275
Employees
15
Employees
1,2763% decrease
Employees
8573% increase
Employees
170
Employees
6932% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
8.8 b
Valuation ($)
257.6 m
Valuation ($)
536.3 m
Valuation ($)
4.9 b
Valuation ($)
5.2 m
Valuation ($)
529.2 m
Valuation ($)
48.6 m

Financial

Revenue (est.)
Revenue (est.)
$3.6b (FY, 2022)
Revenue (est.)
$124.8m (FY, 2023)
Revenue (est.)
$228.6m (FY, 2024)
Revenue (est.)
$38.9m (FY, 2024)
Revenue (est.)
$560.2m (FY, 2024)
Revenue (est.)
N/A
Revenue (est.)
$152.3m (FY, 2024)
Revenue (est.)
N/A
Gross profit
Gross profit
$2.7b (FY, 2022)
Gross profit
N/A
Gross profit
$81.4m (FY, 2024)
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Gross profit
N/A
Net income
Net income
$521.5m (FY, 2022)
Net income
$4.2b (FY, 2023)
Net income
($82.2m) (FY, 2024)
Net income
($77.4m) (FY, 2024)
Net income
($569.2m) (FY, 2024)
Net income
($58m) (FY, 2024)
Net income
($80.9m) (FY, 2024)
Net income
($208m) (FY, 2024)

Operating

Phase I Trials Products
Phase I Trials Products
3 (Sep, 2021)
Phase I Trials Products
4 (Q2, 2021)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase II Trials Products
Phase II Trials Products
12 (Sep, 2021)
Phase II Trials Products
5 (Q2, 2021)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
2 (Sep, 2021)
Phase III Trials Products
1 (Q2, 2021)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 63m
Total funding raised
$ 1.9b
Total funding raised
$ 122.8m
Total funding raised
$ 167.7m
Total funding raised
$ 200.1m
Total funding raised
$ 85m
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Roivant Sciences
HQ
London, GB
Employees
908

Roivant Sciences is a company that develops and commercializes medicines.

View company
Amarin
HQ
Dublin, IE
Employees
275

Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.

View company
Cartesian Therapeutics
HQ
Watertown, US
Employees
15

Cartesian Therapeutics (formerly Selecta Biosciences) is a clinical-stage biopharmaceutical company advancing a differentiated product pipeline to modulate the immune system.

View company
Ultragenyx
HQ
Novato, US
Employees
1,276↓ 3% decrease

Ultragenyx Pharmaceutical is a company that develops therapies for rare genetic diseases.

View company